Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Frøholm LO[au]:

Search results

Items: 1 to 50 of 112

1.

Phenotypic and genomic characterization of pneumococcus-like streptococci isolated from HIV-seropositive patients.

Leegaard TM, Bootsma HJ, Caugant DA, Eleveld MJ, Mannsåker T, Frøholm LO, Gaustad P, Høiby EA, Hermans PW.

Microbiology. 2010 Mar;156(Pt 3):838-48. doi: 10.1099/mic.0.035345-0. Epub 2009 Dec 3.

PMID:
19959577
2.

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.

Guerin PJ, Naess LM, Fogg C, Rosenqvist E, Pinoges L, Bajunirwe F, Nabasumba C, Borrow R, Frøholm LO, Ghabri S, Batwala V, Twesigye R, Aaberge IS, Røttingen JA, Piola P, Caugant DA.

PLoS Negl Trop Dis. 2008;2(12):e342. doi: 10.1371/journal.pntd.0000342. Epub 2008 Dec 2.

3.

Carriage of Streptococcus pneumoniae in healthy Norwegian children attending day-care centres.

Sogstad MK, Aaberge IS, Sørdal JO, Høiby EA, Frøholm LO, Alme AR, Caugant DA.

Eur J Clin Microbiol Infect Dis. 2006 Aug;25(8):510-4.

PMID:
16896824
4.

Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda.

Caugant DA, Fogg C, Bajunirwe F, Piola P, Twesigye R, Mutebi F, Frøholm LO, Rosenqvist E, Batwala V, Aaberge IS, Rottingen JA, Guerin PJ.

Trans R Soc Trop Med Hyg. 2006 Dec;100(12):1159-63. Epub 2006 Jun 12.

PMID:
16765397
5.

Systemic pneumococcal disease in Norway 1995-2001: capsular serotypes and antimicrobial resistance.

Pedersen MK, Høiby EA, Frøholm LO, Hasseltvedt V, Lermark G, Caugant DA.

Epidemiol Infect. 2004 Apr;132(2):167-75.

6.

Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.

Wedege E, Kuipers B, Bolstad K, van Dijken H, Frøholm LO, Vermont C, Caugant DA, van den Dobbelsteen G.

Infect Immun. 2003 Jul;71(7):3775-81.

7.

Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001.

Ouedraogo-Traore R, Høiby EA, Sanou I, Sangare L, Kyelem N, Ye-Ouattara D, Frøholm LO, Caugant DA.

Scand J Infect Dis. 2002;34(11):804-7.

PMID:
12578146
8.

Do HIV-seropositive patients become colonised with drug-resistant microorganisms?

Leegaard TM, Caugant DA, Frøholm LO, Høiby EA, Rønning EJ, Sandven P, Bruun JN.

Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):856-63. Epub 2002 Dec 10.

PMID:
12525920
9.

Emerging antibiotic resistance in Salmonella typhimurium in Norway.

Leegaard TM, Caugnat DA, Frøholm LO, Høiby EA, Lassen J.

Epidemiol Infect. 2000 Dec;125(3):473-80.

10.

Apparent differences in antimicrobial susceptibility as a consequence of national guidelines.

Leegaard TM, Caugant DA, Frøholm LO, Høiby EA.

Clin Microbiol Infect. 2000 Jun;6(6):290-3. No abstract available.

11.

Genomic rearrangements in neisseria meningitidis strains of the ET-5 complex.

Froholm LO, Kolsto AB, Berner JM, Caugant DA.

Curr Microbiol. 2000 Jun;40(6):372-9.

PMID:
10827279
12.

Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine.

Berstad AK, Oftung F, Korsvold GE, Haugen IL, Froholm LO, Holst J, Haneberg B.

Vaccine. 2000 May 8;18(22):2323-30.

PMID:
10738087
13.

Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication.

Smith I, Lehmann AK, Lie L, Digranes A, Caugant DA, Høiby EA, Frøholm LO, Halstensen A.

Epidemiol Infect. 1999 Dec;123(3):373-82.

14.

A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.

Berstad AK, Holst J, Frøholm LO, Haugen IL, Wedege E, Oftung F, Haneberg B.

J Med Microbiol. 2000 Feb;49(2):157-63.

PMID:
10670566
15.
16.
17.
18.

Clonal distribution of invasive Neisseria meningitidis isolates from the Norwegian county of Telemark, 1987 to 1995.

Aakre RK, Jenkins A, Kristiansen BE, Froholm LO.

J Clin Microbiol. 1998 Sep;36(9):2623-8.

19.

Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.

Rosenqvist E, Høiby EA, Bjune G, Aase A, Halstensen A, Lehmann AK, Paulssen J, Holst J, Michaelsen TE, Nøkleby H, Frøholm LO, Closs O.

Dev Biol Stand. 1998;92:323-33.

PMID:
9554288
21.

Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies.

Poolman JT, Kriz-Kuzemenska P, Ashton F, Bibb W, Dankert J, Demina A, Frøholm LO, Hassan-King M, Jones DM, Lind I, et al.

Clin Diagn Lab Immunol. 1995 Jan;2(1):69-72.

22.

Risk of pneumococcal disease in individuals without a spleen.

Aavitsland P, Frøholm LO, Høiby EA, Lystad A.

Lancet. 1994 Nov 26;344(8935):1504. No abstract available.

PMID:
7968138
23.

[All persons without spleen should be given pneumococcal vaccine].

Aaberge IS, Nøkleby H, Frøholm LO.

Tidsskr Nor Laegeforen. 1994 Sep 30;114(23):2732-3. Review. Norwegian.

PMID:
7998017
24.

[High incidence and mortality of systemic pneumococcal disease among persons without spleen].

Aavitsland P, Frøholm LO, Høiby EA, Lystad A.

Tidsskr Nor Laegeforen. 1994 Sep 30;114(23):2711-4. Norwegian.

PMID:
7998010
25.

Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population.

Caugant DA, Høiby EA, Magnus P, Scheel O, Hoel T, Bjune G, Wedege E, Eng J, Frøholm LO.

J Clin Microbiol. 1994 Feb;32(2):323-30.

26.

A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine.

Rosenqvist E, Høiby EA, Wedege E, Caugant DA, Frøholm LO, McGuinness BT, Brooks J, Lambden PR, Heckels JE.

Microb Pathog. 1993 Sep;15(3):197-205.

PMID:
7505873
27.

Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins.

Wedege E, Dalseg R, Caugant DA, Poolman JT, Frøholm LO.

J Med Microbiol. 1993 Jan;38(1):23-8.

PMID:
7678117
28.

Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis.

Caugant DA, Høiby EA, Rosenqvist E, Frøholm LO, Selander RK.

Epidemiol Infect. 1992 Oct;109(2):241-53.

29.

[Genotypes of Neisseria meningitidis strains isolated from patients in the Czech Republic].

Kuzemenská P, Caugant DA, Frøholm LO, Selander RK, Chudácková G.

Cesk Epidemiol Mikrobiol Imunol. 1992 Aug;41(3):129-38. Czech.

PMID:
1388098
30.

Monocyte phagocytosis of opsonized Neisseria meningitidis serogroup B.

Sjursen H, Lehmann V, Naess A, Hervig T, Flø RW, Maehle B, Halstensen AI, Frøholm LO.

APMIS. 1992 Mar;100(3):209-20.

PMID:
1562314
31.

Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.

Bjune G, Closs O, Frøholm LO, Grønnesby JK, Høiby EA, Nøkleby H.

NIPH Ann. 1991 Dec;14(2):81-91; discussion 91-3.

PMID:
1812439
32.

Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.

Fredriksen JH, Rosenqvist E, Wedege E, Bryn K, Bjune G, Frøholm LO, Lindbak AK, Møgster B, Namork E, Rye U, et al.

NIPH Ann. 1991 Dec;14(2):67-79; discussion 79-80.

PMID:
1812438
33.

Immunoblotting studies of vaccinee and patient sera from a Norwegian serogroup B meningococcal vaccination trial.

Wedege E, Bjune G, Frøholm LO, Høiby EA, Rosenqvist E.

NIPH Ann. 1991 Dec;14(2):183-4; discussion 185-6. No abstract available.

PMID:
1812431
34.

Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.

Høiby EA, Rosenqvist E, Frøholm LO, Bjune G, Feiring B, Nøkleby H, Rønnild E.

NIPH Ann. 1991 Dec;14(2):147-55; discussion 155-6.

PMID:
1812429
35.

Meningococcal strains isolated from teenage patients during the serogroup B vaccination trial in Norway: serotyping, serosubtyping, immunotyping and clonal analysis.

Frøholm LO, Caugant DA, Holten E, Høiby EA, Rosenqvist E, Wedege E.

NIPH Ann. 1991 Dec;14(2):139-43; discussion 144-6. No abstract available.

PMID:
1812428
36.

The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.

Høiby EA, Bjune G, Frøholm LO, Eng J, Halstensen A, Rosenqvist E, Rønnild E, Wedege E.

NIPH Ann. 1991 Dec;14(2):107-21; discussion 121-3.

PMID:
1812424
38.

Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986.

Caugant DA, Bol P, Høiby EA, Zanen HC, Frøholm LO.

J Infect Dis. 1990 Oct;162(4):867-74.

PMID:
2119401
39.

Serogroup determination of Neisseria meningitidis by whole-cell ELISA, dot-blotting and agglutination.

Rosenqvist E, Wedege E, Høiby EA, Frøholm LO.

APMIS. 1990 Jun;98(6):501-6.

PMID:
2116811
40.

Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA.

Wedege E, Høiby EA, Rosenqvist E, Frøholm LO.

J Med Microbiol. 1990 Mar;31(3):195-201.

PMID:
2107317
41.

Serogroup A Neisseria meningitidis of clone III-1 present in western Norway as early as 1969-73.

Hjetland R, Caugant DA, Hofstad T, Frøholm LO, Selander RK.

Scand J Infect Dis. 1990;22(2):241-2.

PMID:
2113311
42.

Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89.

Haimanot RT, Caugant DA, Fekadu D, Bjune G, Belete B, Frøholm LO, Høiby EA, Rosenqvist E, Selander RK, Bjorvatn B.

Scand J Infect Dis. 1990;22(2):171-4.

PMID:
2113309
43.

Sulfonamide resistance in Neisseria meningitidis isolates of clones of the ET-5 complex.

Caugant DA, Frøholm LO, Selander RK, Bøvre K.

APMIS. 1989 May;97(5):425-8.

PMID:
2499344
44.

Serum opsonins to serogroup B meningococci in meningococcal disease.

Halstensen A, Sjursen H, Vollset SE, Frøholm LO, Naess A, Matre R, Solberg CO.

Scand J Infect Dis. 1989;21(3):267-76.

PMID:
2502834
45.

Restoration of antibody binding to blotted meningococcal outer membrane proteins using various detergents.

Wedege E, Bryn K, Frøholm LO.

J Immunol Methods. 1988 Oct 4;113(1):51-9.

PMID:
2459253
46.

Meningococcal phenotypic and genotypic characteristics and human antibody levels.

Kristiansen BE, Lind KW, Mevold K, Sørensen B, Frøholm LO, Bryn K, Tjade T, Bøvre K.

J Clin Microbiol. 1988 Oct;26(10):1988-92.

47.

Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.

Rosenqvist E, Harthug S, Frøholm LO, Høiby EA, Bøvre K, Zollinger WD.

J Clin Microbiol. 1988 Aug;26(8):1543-8.

48.

Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers.

Caugant DA, Kristiansen BE, Frøholm LO, Bøvre K, Selander RK.

Infect Immun. 1988 Aug;56(8):2060-8.

49.

Immuno-electronmicroscopy of fimbriae-like structures on Bordetella pertussis serotype 1.3.

Fredriksen JH, Namork E, Frøholm LO.

J Med Microbiol. 1988 Apr;25(4):285-8.

PMID:
2895814
50.

Serum opsonins to group B meningococci.

Sjursen H, Bjerknes R, Halstensen A, Naess A, Frøholm LO, Rosenqvist E, Solberg CO.

Acta Pathol Microbiol Immunol Scand C. 1987 Dec;95(6):283-9.

PMID:
3126623

Supplemental Content

Loading ...
Support Center